| Xpovio | NME | selinexor | To treat adult patients with relapsed or refractory multiple myeloma (RRMM) | Press Release | | 2019/07/03 | KARYOPHARM THERAPEUTICS INC |
| Polivy | Biologics | polatuzumab vedotin-piiq | To treat adult patients with relapsed or refractory diffuse large B-cell lymphoma | Press Release | | 2019/06/10 | GENENTECH |
| Piqray | NME | alpelisib | To treat breast cancer | Press Release | Drug Trials Snapshot | 2019/05/24 | NOVARTIS PHARMS CORP |
| Vyndaqel | NME | tafamidis meglumine | To treat heart disease (cardiomyopathy) caused by transthyretin mediated amyloidosis (ATTR-CM) in adults | Press Release | Drug Trials Snapshot | 2019/05/03 | FOLDRX PHARMS |
| Skyrizi | Biologics | risankizumab-rzaa | To treat moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy | | Drug Trials Snapshot | 2019/04/23 | ABBVIE INC |
| Balversa | NME | erdafitinib | To treat adult patients with locally advanced or metastatic bladder cancer | Press Release | Drug Trials Snapshot | 2019/04/12 | JANSSEN BIOTECH |
| Evenity | Biologics | romosozumab-aqqg | To treat osteoporosis in postmenopausal women at high risk of fracture | Press Release | Drug Trials Snapshot | 2019/04/09 | AMGEN INC |
| Mayzent | NME | siponimod | To treat adults with relapsing forms of multiple sclerosis | Press Release | Drug Trials Snapshot | 2019/03/26 | NOVARTIS PHARMS CORP |
| Sunosi | NME | solriamfetol | To treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea | | Drug Trials Snapshot | 2019/03/20 | JAZZ |
| Zulresso | NME | brexanolone | To treat postpartum depression (PPD) in adult women | Press Release | Drug Trials Snapshot | 2019/03/19 | SAGE THERAP |
| Egaten | NME | triclabendazole | To treat fascioliasis, a parasitic infestation caused by two species of flatworms or trematodes that mainly the affect the liver, sometimes referred to as “liver flukes” | | Drug Trials Snapshot | 2019/02/13 | NOVARTIS PHARMS CORP |
| Cablivi | Biologics | caplacizumab-yhdp | To treat adult patients with acquired thrombotic thrombocytopenic purpura (aTTP) | Press Release | Drug Trials Snapshot | 2019/02/06 | ABLYNX NV |
| JEUVEAU | Biologics | PRABOTULINUMTOXINA-XVFS | For the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients | | Drug Trials Snapshot | 2019/02/01 | EVOLUS INC |
| Ibsrela | NME | tenapanor | To treat irritable bowel syndrome with constipation in adults. | | | 2019-09-12 | ARDELYX INC |
| Nourianz | NME | istradefylline | To treat adult patients with Parkinson’s disease experiencing “off” episodes | Press Release | | 2019-08-27 | KYOWA KIRIN |
| Ga-68-DOTATOC | NME | Ga-68-DOTATOC | For use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) | | Drug Trials Snapshot | 2019-08-21 | UNIV IOWA HOSPS AND CLINICS PET IMAGING CENTER |
| Xenleta | NME | lefamulin | To treat adults with community-acquired bacterial pneumonia | Press Release | Drug Trials Snapshot | 2019-08-19 | NABRIVA THERAPEUTICS US INC |
| Rinvoq | NME | upadacitinib | To treat adults with moderately to severely active rheumatoid arthritis | | Drug Trials Snapshot | 2019-08-16 | ABBVIE INC |
| Inrebic | NME | fedratinib | To treat adult patients with intermediate-2 or high-risk primary or secondary myelofibrosis | Press Release | Drug Trials Snapshot | 2019-08-16 | IMPACT BIOMEDICINES INC |
| Rozlytrek | NME | entrectinib | To treat adult and pediatric patients 12 years of age and older with solid tumors | Press Release | Drug Trials Snapshot | 2019-08-15 | GENENTECH INC |
